Pascal Touchon's Insider Trades & SAST Disclosures
Pascal Touchon's most recent trade in Atara Biotherapeutics Inc was a trade of 2,762 Common Stock done at an average price of $6.6 . Disclosure was reported to the exchange on Aug. 16, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Pascal Touchon.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.63 per share. | 16 Aug 2024 | 2,762 | 70,403 (0%) | 0% | 6.6 | 18,309 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.63 per share. | 16 Aug 2024 | 276 | 70,127 (0%) | 0% | 6.6 | 1,830 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 9,680 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 9,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 7,075 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 16 May 2024 | 81,506 | 1,829,146 (3%) | 0% | 0.6 | 50,289 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 04 Mar 2024 | 24,844 | 1,910,652 (3%) | 0% | 0.7 | 17,888 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 1,280,000 | 1,935,496 (3%) | 2% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 27 Jun 2023 | 14,291 | 706,671 (1%) | 0% | 1.7 | 23,723 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.04 per share. | 16 May 2023 | 29,766 | 720,962 (1%) | 0% | 2.0 | 60,633 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.63 per share. | 02 Mar 2023 | 15,679 | 750,728 (1%) | 0% | 3.6 | 56,868 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 730,600 | 730,600 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 324,711 | 766,407 (1%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.03 per share. | 16 Aug 2022 | 14,806 | 457,287 (0%) | 0% | 5.0 | 74,548 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.20 per share. | 27 Jun 2022 | 14,220 | 472,093 (0%) | 0% | 7.2 | 102,384 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.32 per share. | 17 May 2022 | 13,913 | 486,313 (0%) | 0% | 5.3 | 73,962 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 339,419 | 339,419 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 180,565 | 509,054 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 01 Mar 2022 | 8,828 | 500,226 (0%) | 0% | 9.9 | 87,009 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 17.12 per share. | 16 Nov 2021 | 8,402 | 328,489 (0%) | 0% | 17.1 | 143,816 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 17 Aug 2021 | 8,223 | 336,891 (0%) | 0% | 12.5 | 103,051 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.32 per share. | 25 Jun 2021 | 14,194 | 345,114 (0%) | 0% | 16.3 | 231,660 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.55 per share. | 18 May 2021 | 8,313 | 359,308 (0%) | 0% | 14.5 | 120,954 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.74 per share. | 02 Mar 2021 | 4,887 | 367,621 (0%) | 0% | 16.7 | 81,808 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 176,886 | 176,886 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 117,187 | 372,508 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.77 per share. | 17 Nov 2020 | 4,716 | 255,321 (0%) | 0% | 19.8 | 93,254 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.09 per share. | 18 Aug 2020 | 4,807 | 260,037 (0%) | 0% | 12.1 | 58,117 | Common Stock |
| Atara Biotherapeutics Inc | Pascal Touchon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.92 per share. | 25 Jun 2020 | 12,135 | 264,844 (0%) | 0% | 12.9 | 156,784 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges